Research ArticleArticle
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
Eloi Garcia-Vives, Alfons Segarra-Medrano, Ferran Martinez-Valle, Irene Agraz and Roser Solans-Laque
The Journal of Rheumatology June 2019, jrheum.190065; DOI: https://doi.org/10.3899/jrheum.190065
Eloi Garcia-Vives
From the Autoimmune Systemic Diseases Unit, Internal Medicine Department, and Nephrology Department, Vall d’Hebron University Hospital, Barcelona, Spain. E. Garcia-Vives, MD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; A. Segarra-Medrano, PhD, Nephrology Department, Vall d’Hebron University Hospital; F. Martinez-Valle, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; I. Agraz, PhD, Nephrology Department, Vall d’Hebron University Hospital; R. Solans-Laque, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital. E. Garcia-Vives and R. Solans-Laque declare that both have contributed equally to the paper. Address correspondence to R. Solans-Laque, Vall d’Hebron University Hospital, Internal Medicine, Pg Vall d’Hebron 119-129, Barcelona 08035, Spain. E-mail: rsolans@vhebron.net. Accepted for publication May 23, 2019.
Alfons Segarra-Medrano
From the Autoimmune Systemic Diseases Unit, Internal Medicine Department, and Nephrology Department, Vall d’Hebron University Hospital, Barcelona, Spain. E. Garcia-Vives, MD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; A. Segarra-Medrano, PhD, Nephrology Department, Vall d’Hebron University Hospital; F. Martinez-Valle, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; I. Agraz, PhD, Nephrology Department, Vall d’Hebron University Hospital; R. Solans-Laque, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital. E. Garcia-Vives and R. Solans-Laque declare that both have contributed equally to the paper. Address correspondence to R. Solans-Laque, Vall d’Hebron University Hospital, Internal Medicine, Pg Vall d’Hebron 119-129, Barcelona 08035, Spain. E-mail: rsolans@vhebron.net. Accepted for publication May 23, 2019.
Ferran Martinez-Valle
From the Autoimmune Systemic Diseases Unit, Internal Medicine Department, and Nephrology Department, Vall d’Hebron University Hospital, Barcelona, Spain. E. Garcia-Vives, MD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; A. Segarra-Medrano, PhD, Nephrology Department, Vall d’Hebron University Hospital; F. Martinez-Valle, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; I. Agraz, PhD, Nephrology Department, Vall d’Hebron University Hospital; R. Solans-Laque, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital. E. Garcia-Vives and R. Solans-Laque declare that both have contributed equally to the paper. Address correspondence to R. Solans-Laque, Vall d’Hebron University Hospital, Internal Medicine, Pg Vall d’Hebron 119-129, Barcelona 08035, Spain. E-mail: rsolans@vhebron.net. Accepted for publication May 23, 2019.
Irene Agraz
From the Autoimmune Systemic Diseases Unit, Internal Medicine Department, and Nephrology Department, Vall d’Hebron University Hospital, Barcelona, Spain. E. Garcia-Vives, MD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; A. Segarra-Medrano, PhD, Nephrology Department, Vall d’Hebron University Hospital; F. Martinez-Valle, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; I. Agraz, PhD, Nephrology Department, Vall d’Hebron University Hospital; R. Solans-Laque, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital. E. Garcia-Vives and R. Solans-Laque declare that both have contributed equally to the paper. Address correspondence to R. Solans-Laque, Vall d’Hebron University Hospital, Internal Medicine, Pg Vall d’Hebron 119-129, Barcelona 08035, Spain. E-mail: rsolans@vhebron.net. Accepted for publication May 23, 2019.
Roser Solans-Laque
From the Autoimmune Systemic Diseases Unit, Internal Medicine Department, and Nephrology Department, Vall d’Hebron University Hospital, Barcelona, Spain. E. Garcia-Vives, MD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; A. Segarra-Medrano, PhD, Nephrology Department, Vall d’Hebron University Hospital; F. Martinez-Valle, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital; I. Agraz, PhD, Nephrology Department, Vall d’Hebron University Hospital; R. Solans-Laque, PhD, Autoimmune Systemic Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital. E. Garcia-Vives and R. Solans-Laque declare that both have contributed equally to the paper. Address correspondence to R. Solans-Laque, Vall d’Hebron University Hospital, Internal Medicine, Pg Vall d’Hebron 119-129, Barcelona 08035, Spain. E-mail: rsolans@vhebron.net. Accepted for publication May 23, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
Eloi Garcia-Vives, Alfons Segarra-Medrano, Ferran Martinez-Valle, Irene Agraz, Roser Solans-Laque
The Journal of Rheumatology Jun 2019, jrheum.190065; DOI: 10.3899/jrheum.190065
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
Eloi Garcia-Vives, Alfons Segarra-Medrano, Ferran Martinez-Valle, Irene Agraz, Roser Solans-Laque
The Journal of Rheumatology Jun 2019, jrheum.190065; DOI: 10.3899/jrheum.190065